Many oncologists recommend medical marijuana clinically despite not feeling sufficiently knowledgeable about its utility.
Patients who use medical marijuana may be more likely to use prescription drugs for both medical and nonmedical purposes.
Implementing medical or adult-use marijuana laws may reduce the rate of opioid prescribing for Medicaid enrollees.
Since the legalization of medical marijuana, clinicians must come up with appropriate responses to requests for treatment in pediatric end-of-life settings.
Various strategies to reduce opioid overdose deaths have been implemented and it has been suggested that access to medical cannabis may lead to a reduction in opioid use for pain management.
Medical marijuana laws that include a "liberal" allowance of the drug to dispensaries may contribute to reducing opioid overdose-related deaths in Medicare Part-D and Medicaid beneficiaries.
The benefits associated with medical cannabis therapy may be overestimated due to inadequate blinding in clinical trials.
Medical marijuana laws may be connected to increased rates of illicit cannabis use and cannabis use disorder, leading some users to experience negative consequences, such as motor vehicle accidents.
Medical marijuana, as a botanical and a scheduled drug does not fit the FDA paradigm for drug approval, a major impediment to its use in research.
Cannabis use disorder is also rising faster in states with legalization laws
Pot-related poison control calls and hospital discharges spike with wider availability.
Every day the staff at Clinical Pain Advisor browses the Web for stories on chronic pain, acute pain, low back pain, diabetic neuropathy, fibromyalgia and other painful health conditions that readers might have missed the day before and lists some of their favorite articles in a daily column to provide clinicians with a resource they can check first thing in the morning.
Some parents are now demanding that politicians and state legislators legalize the use of marijuana for treating epileptic children.
For Echo, reducing the therapeutic dose is key to improving compliance and providing both patients and healthcare providers with a more cost-effective therapy.
Clinical Pain Advisor Articles
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis